Results
2308
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
2,308 companies
Belluscura
Market Cap: UK£3.8m
Develops and commercialize oxygen related medical device products in the United States.
BELL
UK£0.0095
7D
-7.3%
1Y
-94.3%
CordovaCann
Market Cap: US$5.1m
Engages in identifying, funding, developing, and managing operations in the cannabis value chain business.
LVRL.F
US$0.046
7D
-34.3%
1Y
-37.4%
CompuMed
Market Cap: US$5.0m
An enterprise telemedicine solutions company, provides clinical care services for patients and medical facilities.
CMPD
US$3.80
7D
26.2%
1Y
123.5%
IM Cannabis
Market Cap: CA$7.0m
Engages in breeding, growing, and supply of medical cannabis products in Israel and Germany.
IMCC
CA$2.27
7D
-3.4%
1Y
-60.2%
Palatin Technologies
Market Cap: US$5.0m
A biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States.
0KF3
US$0.15
7D
38.2%
1Y
-92.6%
CanadaBis Capital
Market Cap: CA$6.9m
Engages in the production and sale of recreational cannabis and cannabis extracts in Canada.
CANB
CA$0.05
7D
0%
1Y
-44.4%
BioElectronics
Market Cap: US$4.9m
An electroceutical company, engages in the development and sale of wearable, neuromodulation devices to mitigate neurological diseases and enhance quality of life worldwide.
BIEL
US$0.0002
7D
33.3%
1Y
33.3%
Genflow Biosciences
Market Cap: UK£3.7m
Operates as a biotechnology company that focuses on developing biological interventions aimed at tackling the effects of ageing, slowing, and halting the ageing process, and reducing the incidence of age-related diseases with increase in health span in the United Kingdom and Belgium.
GENF
UK£0.0095
7D
-5.0%
1Y
-55.8%
SenesTech
Market Cap: US$4.9m
Engages in the development and commercialization of a technology for managing animal pest populations through fertility control.
SNES
US$2.81
7D
1.1%
1Y
-60.3%
Core One Labs
Market Cap: CA$6.8m
Operates as a psychedelic research and development company.
COOL
CA$0.14
7D
0%
1Y
-46.3%
Therma Bright
Market Cap: CA$6.8m
Acquires, develops, manufactures, and markets proprietary healthcare and medical devices focused on respiratory diseases, vascular health, and consumer medical devices for consumer and institutional marketplace.
THRM
CA$0.015
7D
0%
1Y
0%
Innovative Holdings Alliance
Market Cap: US$4.9m
A medical technology holding company, offers personal care products in North America.
IHAI
US$0.093
7D
-13.5%
1Y
-7.0%
DATATRAK International
Market Cap: US$4.8m
A technology and services company, provides unified clinical solutions and related services for the clinical trials industry.
DTRK
US$0.23
7D
-25.0%
1Y
-52.4%
Autonomix Medical
Market Cap: US$4.8m
A development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system.
AMIX
US$1.95
7D
11.4%
1Y
-95.8%
Eastgate Biotech
Market Cap: US$4.8m
A development stage company, develops novel formulations of natural compounds and pharmaceutical products.
ETBI
US$0.0045
7D
0%
1Y
n/a
TrivarX
Market Cap: AU$7.4m
A health technology company, engages in the development of AI-driven, scientifically-based devices for screening and diagnosis of behavioral health conditions in Australia and the United States.
TRI
AU$0.012
7D
-7.7%
1Y
-60.0%
Epsilon Healthcare
Market Cap: AU$7.2m
Epsilon Healthcare Limited operates as a healthcare and pharmaceuticals company primarily in Australia and Canada.
EPN
AU$0.024
7D
0%
1Y
20.0%
Invion
Market Cap: AU$7.4m
A clinical-stage life-sciences company, researches and develops Photosoft technology for the treatment of cancers, atherosclerosis, and infectious diseases in Australia.
IVX
AU$0.081
7D
-19.0%
1Y
-83.8%
Ecofibre
Market Cap: AU$7.3m
Engages in the polymer, health care, and hemp seed genetics businesses in the United States and Australia.
EOF
AU$0.02
7D
0%
1Y
-63.6%
Virax Biolabs Group
Market Cap: US$4.7m
A biotechnology company, distributes, markets, and sells diagnostics test kits for the prevention, detection, diagnosis, and risk management of viral diseases in the field of immunology.
VRAX
US$1.08
7D
0.9%
1Y
30.1%
dorsaVi
Market Cap: AU$7.3m
Engages in the development and sale of motion analysis technologies in Australia, Europe, and the United States.
DVL
AU$0.01
7D
11.1%
1Y
-28.6%
Conduit Pharmaceuticals
Market Cap: US$4.7m
A clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical needs in the areas of autoimmune diseases and idiopathic male infertility.
CDT
US$0.39
7D
-4.7%
1Y
-99.9%
Sharps Technology
Market Cap: US$4.7m
A medical device and pharmaceutical packaging company, engages in the design, research and development, manufacturing, and commercialization of safety syringe products in the United States.
STSS
US$4.57
7D
-1.9%
1Y
-99.7%
Zero Candida Technologies
Market Cap: CA$6.5m
A technology company, designs, develops, manufactures, and sells non-drug blue light therapy devices for the treatment of vulvo-vaginal candidiasis.
ZCT
CA$0.33
7D
-2.9%
1Y
n/a
Valeo Pharma
Market Cap: US$4.6m
A specialty pharmaceutical company, engages in the acquisition, in-licensing brands, and sale of pharmaceuticals and hospital specialty products for unmet medical needs in Canada.
VPHI.F
US$0.047
7D
0%
1Y
-59.4%
WEED
Market Cap: US$4.6m
Focuses on the development and application of cannabis-derived compounds for the treatment of human diseases and animal ailments in the United States and Australia.
BUDZ
US$0.034
7D
8.8%
1Y
-56.3%
Reflect Scientific
Market Cap: US$4.6m
Through its subsidiaries, engages in the design, development, and sale of scientific equipment for the life science and manufacturing industries worldwide.
RSCF
US$0.054
7D
34.5%
1Y
0.2%
Celadon Pharmaceuticals
Market Cap: UK£3.4m
Engages in the research, cultivation, manufacturing, and sale of cannabis-based medicines.
CEL
UK£0.05
7D
0%
1Y
-94.6%
Affimed
Market Cap: US$4.6m
A clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States and Germany.
AFMD
US$0.28
7D
-59.7%
1Y
-94.6%
T2 Biosystems
Market Cap: US$4.6m
An in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally.
TTOO
US$0.16
7D
12.2%
1Y
-97.3%
Alaunos Therapeutics
Market Cap: US$4.5m
A clinical-stage oncology-focused cell therapy company, develops small molecules to treat obesity and other metabolic disorders.
TCRT
US$2.84
7D
-0.4%
1Y
-74.4%
Quoin Pharmaceuticals
Market Cap: US$4.5m
A late stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases in the United States.
QNRX
US$7.70
7D
25.8%
1Y
-71.2%
PD-Rx Pharmaceuticals
Market Cap: US$4.5m
Engages in the repackaging and distribution of prepackaged pharmaceutical products for the healthcare industry in the United States.
PDRX
US$2.75
7D
0%
1Y
n/a
Bakhu Holdings
Market Cap: US$4.5m
Produces, manufactures, and sells cannabis-related byproducts for medical, food additive, and recreational use.
BKUH
US$0.015
7D
0%
1Y
-87.7%
Xenetic Biosciences
Market Cap: US$4.5m
A biopharmaceutical company, focuses on advancing immune-oncology technologies to treat cancers.
XBIO
US$2.91
7D
-6.1%
1Y
-22.8%
Invex Therapeutics
Market Cap: AU$7.0m
A biopharmaceutical company, engages in the research and development of treatments for neurological conditions in Australia.
IXC
AU$0.093
7D
-4.1%
1Y
22.4%